@article {10.3844/ajisp.2015.68.73,
article_type = {journal},
title = {Vaccine against Jembrana Disease Virus Infection: A Summary Findings},
author = {Kusumawati, Asmarani and Wanahari, Tenri Ashari and Astuti, Pudji and Kurniasih, and Mappakaya, Basofi Ashari and Wuryastuty, Hastari},
volume = {11},
year = {2015},
month = {Sep},
pages = {68-73},
doi = {10.3844/ajisp.2015.68.73},
url = {https://thescipub.com/abstract/ajisp.2015.68.73},
abstract = {Jembrana disease constitutes the main concern in cattle industry especially in Indonesia and Australia as it has caused important economic losses due to mortality of cattle. The pathology of the disease is unusual for a lentivirus infection as it is associated with a severe, often lethal disease syndrome and a short incubation period in cattle. For lack of efficient medical treatment of JDV-infected cattle, vaccination may therefore constitute an effective measure for the prevention or eradication of Jembrana disease. Up to date, only one type of vaccine has been reported and tested. It is based on inactivated, tissue-derived virus antigens (Tabanan/87 isolate, JDVTAB/87). This review summarize show current Jembrana disease vaccine was developed as well as evaluated and how these information might be useful in future vaccine design.},
journal = {American Journal of Immunology},
publisher = {Science Publications}
}